World's Best Scientists 2026 revealed!
Mark H. Norman

Mark H. Norman

D-Index & Metrics

Chemistry

D-Index
48
Citations
8078
World Ranking
15257
National Ranking
416

Mark H. Norman publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Mark H. Norman sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 133 publications — 9th percentile

9% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Mark H. Norman D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Mark H. Norman sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 48 D-Index — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Mark H. Norman is affiliated with Amgen (Canada) in Canada. Their research primarily focuses on Medicine, with a specialization in Cardiology and Cardiovascular Medicine. This specialization is reflected in their publications and the topics they explore within their work.

Norman's published works demonstrate a strong emphasis on atrial fibrillation management and outcomes, as well as cardiac arrhythmias and treatments. They also engage in studies related to health systems, economic evaluations, and quality of life, alongside literary interests in folklore, mythology, and literature studies.

Their research has been featured in the journal Heart Rhythm, where they have contributed multiple papers. Notable recent publications include:

  • CA-528-03 A REGISTRY REVIEW UPDATE OF 7120 CATHETER ABLATIONS FOR ATRIAL FIBRILLATION USING A DEDICATED ESOPHAGEAL TEMPERATURE CONTROL DEVICE FOR PROTECTION, 2022, Heart Rhythm
  • PO-711-03 A RANDOMISED COMPARISON OF METHODOLOGY IN CRYOBALLOON ABLATION FOR ATRIAL FIBRILLATION: RESULTS AT UP TO A DECADE, 2022, Heart Rhythm
  • PO-06-126 MULTI-CENTER ANALYSIS OF ONE-YEAR FREEDOM FROM ARRHYTHMIA FOLLOWING RADIOFREQUENCY ABLATION USING PROACTIVE ESOPHAGEAL COOLING, 2024, Heart Rhythm

These works collectively contribute to the understanding of treatment efficacy and procedural outcomes in atrial fibrillation, including catheter ablation techniques and esophageal temperature control protocols.

Norman has frequently collaborated with several researchers, including:

  • Zaki Akhtar
  • Abhay Bajpai
  • Zia Zuberi
  • Manav Sohal
  • Mark M. Gallagher

Their academic output also extends beyond journal articles. Norman has authored at least one book, The Folklore Of Devon, published by University of Exeter Press eBooks in 2022, reflecting interdisciplinary interests that include literature and cultural studies.

Best Publications

  • Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans.

    Narender R. Gavva;James J.S. Treanor;Andras Garami;Liang Fang

  • AMG 9810 [(E)-3-(4-t-Butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a Novel Vanilloid Receptor 1 (TRPV1) Antagonist with Antihyperalgesic Properties

    Narender R. Gavva;Rami Tamir;Yusheng Qu;Lana Klionsky

  • Vanilloid receptor ligands and their use in treatments

    Yunxin Y. Bo;Partha P. Chakrabarti;Ning Chen;Elizabeth M. Doherty

  • The Vanilloid Receptor TRPV1 Is Tonically Activated In Vivo and Involved in Body Temperature Regulation

    Narender R. Gavva;Anthony W. Bannon;Sekhar Surapaneni;David N. Hovland

  • The Transient Receptor Potential Vanilloid-1 Channel in Thermoregulation: A Thermosensor It Is Not

    Andrej A. Romanovsky;Maria C. Almeida;Andras Garami;Alexandre A. Steiner;Alexandre A. Steiner

  • Nonthermal Activation of Transient Receptor Potential Vanilloid-1 Channels in Abdominal Viscera Tonically Inhibits Autonomic Cold-Defense Effectors

    Alexandre A Steiner;Victoria F Turek;Maria C Almeida;Jeffrey J Burmeister

  • Effect of Linking Bridge Modifications on the Antipsychotic Profile of Some Phthalimide and Isoindolinone Derivatives

    Mark H. Norman;Douglas J. Minick;Greg C. Rigdon

  • Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats.

    Sonya G. Lehto;Rami Tamir;Hong Deng;Lana Klionsky

  • Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade.

    Narender R. Gavva;Anthony W. Bannon;David N. Hovland;Sonya G. Lehto

  • [1,2,4]Triazolo[4,3-a]pyridinderivater der er nyttige som inhibitorer for hepatocytvækstfaktorreceptoren

    Bauer David;Bellon Steven;Booker Shon;Boezio Alessandro

  • Inhibitors of pi3 kinase

    Yunxin Y. Bo;Shon Booker;Marian Bryan;Holly L. Deak

  • Structure-activity relationships of a series of pyrrolo[3,2-d]pyrimidine derivatives and related compounds as neuropeptide Y5 receptor antagonists.

    Mark H. Norman;Ning Chen;Zhidong Chen;Christopher Fotsch

  • Nitrogen-containing heterocyclyl ketones and their use as c-met inhibitors

    Brian K. Albrecht;Steven Bellon;Shon Booker;Alan C. Cheng

  • Discovery of a Potent, Selective, and Orally Bioavailable c-Met Inhibitor: 1-(2-Hydroxy-2-methylpropyl)-N-(5-(7-methoxyquinolin-4-yloxy)pyridin-2-yl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamide (AMG 458)

    Longbin Liu;Aaron Siegmund;Ning Xi;Paula Kaplan-Lefko

  • Discovery of Potent, Orally Available Vanilloid Receptor-1 Antagonists. Structure−Activity Relationship of N-Aryl Cinnamides

    Elizabeth M. Doherty;Christopher Fotsch;Yunxin Bo;Partha P. Chakrabarti

  • Discovery and Optimization of a Series of Benzothiazole Phosphoinositide 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Dual Inhibitors

    Noel D. D’Angelo;Tae-Seong Kim;Kristin Andrews;Shon K. Booker

  • Fused heterocyclic derivatives and methods of use

    Brian K. Albrecht;David Bauer;Steven Bellon;Christiane M. Bode

  • Acyclic stereoselection. 29. Stereoselection in the Michael addition reaction. 1. The Mukaiyama-Michael reaction

    Clayton H. Heathcock;Mark H. Norman;David E. Uehling

  • Design of Potent, Orally Available Antagonists of the Transient Receptor Potential Vanilloid 1. Structure−Activity Relationships of 2-Piperazin-1-yl-1H-benzimidazoles

    Vassil I. Ognyanov;Chenera Balan;Anthony W. Bannon;Yunxin Bo

  • Structure-based design of novel class II c-Met inhibitors: 1. Identification of pyrazolone-based derivatives.

    Mark H. Norman;Longbin Liu;Matthew Lee;Ning Xi

Frequent Co-Authors

Richard J. Lewis
Richard J. Lewis University of Queensland
Michael D. Bartberger
Michael D. Bartberger Amgen (United States)
Clayton H. Heathcock
Clayton H. Heathcock University of California, Berkeley
Christopher Hulme
Christopher Hulme University of Arizona

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Chemistry opens doors to diverse career paths, many of which can be explored through related online degrees and specialized training programs. For example, an important stepping stone in legal settings is a paralegal studies associate degree, which prepares students for roles that intersect with chemical patent law or compliance.

The pharmaceutical field offers promising opportunities for Chemistry graduates. Those interested in the business side might consider learning how to get into pharmaceutical sales, combining scientific knowledge with communication skills to support medication marketing and education.

For a more intensive clinical path, becoming a pharmacist is a highly respected goal. Though demanding, information on is it hard to become a pharmacist provides insights into the educational rigor and career rewards associated with this profession.

Alternatively, hands-on roles in forensic science and pathology, such as an autopsy technician, support the investigation of diseases and causes of death. Learning how to become an autopsy technician highlights the specialized education and job outlook for this niche.

Exploring these related fields enriches the practical applications of a Chemistry degree and enhances career versatility, especially through accessible online programs.

Best Scientists Citing Mark H. Norman

Trending Scientists

Recently Published Articles